Vaccine Therapy Plus Interleukin-2 in Treating Patients With Stage III or Stage IV Melanoma
Clinical trial NCT00003222 · COMPLETED
Trial details
- NCT number
- NCT00003222
- Sponsor
- University of Virginia
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 1998-04-01
- Primary completion
- 2003-09-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.